In Silico Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Silico Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-07-25
DOI
10.3389/fphar.2018.00800
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current Status and Future Prospects of Small–molecule Protein–protein Interaction (PPI) Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
- (2018) Georgia Melagraki et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- QSAR-Driven Design and Discovery of Novel Compounds With Antiplasmodial and Transmission Blocking Activities
- (2018) Marilia N. N. Lima et al. Frontiers in Pharmacology
- Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design
- (2018) Shaherin Basith et al. Frontiers in Pharmacology
- e-Bitter: Bitterant Prediction by the Consensus Voting From the Machine-Learning Methods
- (2018) Suqing Zheng et al. Frontiers in Chemistry
- Structural Basis of Small-Molecule Aggregate Induced Inhibition of a Protein–Protein Interaction
- (2017) Jonathan M. Blevitt et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
- (2017) Georgia Melagraki et al. PLoS Computational Biology
- OpenMM 7: Rapid development of high performance algorithms for molecular dynamics
- (2017) Peter Eastman et al. PLoS Computational Biology
- Targeting protein–protein interactions, a wide open field for drug design
- (2016) May Bakail et al. COMPTES RENDUS CHIMIE
- Computer Aided Drug Design: Success and Limitations
- (2016) Mohammad Hassan Baig et al. CURRENT PHARMACEUTICAL DESIGN
- Counting on natural products for drug design
- (2016) Tiago Rodrigues et al. Nature Chemistry
- Rheumatoid arthritis: current and future trends
- (2016) Kritika Chaudhari et al. NATURE REVIEWS DRUG DISCOVERY
- State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors
- (2015) Chunquan Sheng et al. CHEMICAL SOCIETY REVIEWS
- ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
- (2015) James A. Maier et al. Journal of Chemical Theory and Computation
- The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins
- (2015) Dima Kozakov et al. Nature Protocols
- Ligand deconstruction: Why some fragment binding positions are conserved and others are not
- (2015) Dima Kozakov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multi-Objective Molecular De Novo Design by Adaptive Fragment Prioritization
- (2014) Michael Reutlinger et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Hot spot-based design of small-molecule inhibitors for protein–protein interactions
- (2014) Wenxing Guo et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
- (2014) Michelle R. Arkin et al. CHEMISTRY & BIOLOGY
- Enalos InSilicoNano platform: an online decision support tool for the design and virtual screening of nanoparticles
- (2014) Georgia Melagraki et al. RSC Advances
- Druggable protein–protein interactions – from hot spots to hot segments
- (2013) Nir London et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Assessing the Performance of MM/PBSA and MM/GBSA Methods. 3. The Impact of Force Fields and Ligand Charge Models
- (2013) Lei Xu et al. JOURNAL OF PHYSICAL CHEMISTRY B
- A Metal-Based Inhibitor of Tumor Necrosis Factor-α
- (2012) Chung-Hang Leung et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Small-Molecule Inhibitors of Protein-Protein Interactions: How to Mimic a Protein Partner
- (2012) David C. Fry CURRENT PHARMACEUTICAL DESIGN
- Features of protein–protein interactions that translate into potent inhibitors: topology, surface area and affinity
- (2012) Matthew C. Smith et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Small-molecule inhibitors of the interaction between TNF and TNFR
- (2012) Jessica M Davis et al. Future Medicinal Chemistry
- 2P2Idb: a structural database dedicated to orthosteric modulation of protein–protein interactions
- (2012) Marie Jeanne Basse et al. NUCLEIC ACIDS RESEARCH
- Structure-Based Repurposing of FDA-Approved Drugs as TNF-α Inhibitors
- (2011) Chung-Hang Leung et al. ChemMedChem
- A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNF
- (2011) Eleni Douni et al. HUMAN MOLECULAR GENETICS
- Predictions of Hot Spot Residues at Protein-Protein Interfaces Using Support Vector Machines
- (2011) Stefano Lise et al. PLoS One
- Structure-Based Discovery of Natural-Product-like TNF-α Inhibitors
- (2010) Daniel Shiu-Hin Chan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Understanding and Predicting Druggability. A High-Throughput Method for Detection of Drug Binding Sites
- (2010) Peter Schmidtke et al. JOURNAL OF MEDICINAL CHEMISTRY
- HotPoint: hot spot prediction server for protein interfaces
- (2010) N. Tuncbag et al. NUCLEIC ACIDS RESEARCH
- Protein-protein docking benchmark version 4.0
- (2010) Howook Hwang et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Transient Protein-Protein Interactions: Structural, Functional, and Network Properties
- (2010) James R. Perkins et al. STRUCTURE
- Inhibition of protein–protein interactions using designed molecules
- (2009) Andrew J. Wilson CHEMICAL SOCIETY REVIEWS
- Making drug design second nature
- (2009) Dan L. Sackett et al. Nature Chemistry
- Predicting druggable binding sites at the protein–protein interface
- (2008) Jonathan C. Fuller et al. DRUG DISCOVERY TODAY
- Suramin: Clinical Uses and Structure-Activity Relationships
- (2008) Ross McGeary et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Metabolic Activation of a Novel 3-Substituted Indole-Containing TNF-α Inhibitor: Dehydrogenation and Inactivation of CYP3A4
- (2007) Hao Sun et al. CHEMICAL RESEARCH IN TOXICOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started